Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
12th Feb 20215:02 pmRNS2019 Redemption Portfolio
12th Feb 20215:00 pmRNSNet Asset Value - Month End Final
5th Feb 20214:43 pmRNSNet Asset Value- Weekly Estimate
29th Jan 20215:45 pmRNSCompany Update
14th Jan 20213:11 pmRNSNet Asset Value - Weekly Estimate
7th Jan 20215:17 pmRNSNet Asset Value - Weekly Estimate
31st Dec 202012:14 pmRNSNet Asset Value - Weekly Estimate
24th Dec 202012:21 pmRNSNet Asset Value - Weekly Estimate
23rd Dec 20204:57 pmRNS2019 Redemption Portfolio
23rd Dec 20204:43 pmRNSNet Asset Value - Month End Final
18th Dec 202012:44 pmRNSResult of Extraordinary General Meeting
17th Dec 20204:45 pmRNSNet Asset Value - Weekly Estimate
9th Dec 20204:39 pmRNSNet Asset Value - Weekly Estimate
9th Dec 202011:51 amRNSBlueCrest Settlement
4th Dec 20204:12 pmRNSNet Asset Value - Weekly Estimate
30th Nov 202010:34 amRNS2019 Redemption Portfolio
30th Nov 202010:31 amRNSNet Asset Value - Month End Final
30th Nov 202010:30 amRNSDirector/PDMR Shareholding
27th Nov 20207:00 amRNSPublication of Circular
25th Nov 20205:07 pmRNSNet Asset Value - Weekly Estimate
17th Nov 20204:44 pmRNSNet Asset Value - Weekly Estimate
11th Nov 20204:55 pmRNSNet Asset Value - Weekly Estimate
5th Nov 20204:29 pmRNSNet Asset Value - Weekly Estimate
29th Oct 20204:21 pmRNSNet Asset Value - Weekly Estimate
29th Oct 20203:53 pmRNS2019 Redemption Portfolio
29th Oct 20203:21 pmRNSNet Asset Value - Month-end Final
21st Oct 20204:49 pmRNSNet Asset Value - Weekly Estimate
21st Oct 20204:42 pmRNSCash Exit Payment
19th Oct 202012:57 pmRNSNet Asset Value - Weekly Estimate
7th Oct 20204:49 pmRNSNet Asset Value - Weekly Estimate
1st Oct 20203:41 pmRNSNet Asset Value - Weekly Estimate
28th Sep 20201:09 pmRNS2019 Redemption Portfolio
25th Sep 20205:52 pmRNSNet Asset Value - Month End Final
25th Sep 20205:50 pmRNSHalf-year Report
24th Sep 20204:55 pmRNSNet Asset Value - Weekly Estimate
18th Sep 20203:31 pmRNSNet Asset Value - Weekly Estimate
18th Sep 202012:40 pmRNSNet Asset Value - Weekly Estimate
18th Sep 202012:12 pmRNSNet Asset Value - Weekly Estimate
17th Sep 20204:03 pmRNSNet Asset Value - Weekly Estimate
16th Sep 20205:43 pmRNSRevision to previously announced NAVs
4th Sep 20207:00 amRNSPotential revision to previously announced NAVs
2nd Sep 20208:35 amRNS2019 Redemption Portfolio
28th Aug 20205:06 pmRNSNet Asset Value - Month End Final
28th Aug 20204:59 pmRNSNet Asset Value - Weekly Estimate
28th Aug 20204:51 pmRNSNet Asset Value - Revised NAVs
20th Aug 20204:17 pmRNSNet Asset Value - Weekly Estimate
13th Aug 20201:06 pmRNSNet Asset Value - Weekly Estimate
7th Aug 20204:37 pmRNSNet Asset Value(s) - Weekly Estimate
5th Aug 202010:34 amRNSResult of AGM
31st Jul 20204:39 pmRNSCash Exit Payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.